Alzheimer's disease Archives | Page 2 of 3 | Be Korea-savvy
Taconic Biosciences Launches Alzheimer’s Disease Mouse Model

Taconic Biosciences Launches Alzheimer’s Disease Mouse Model

RENSSELAER, N.Y., Nov. 4 (Korea Bizwire) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, expands its robust neurodegeneration portfolio with the launch of a new Alzheimer’s disease model, the ARTE10 mouse model.  Exclusively available from Taconic, the ARTE10 is a transgenic mouse model expressing mutant human APP and PS1 genes.  This combination manifests [...]

Vielight Commences Pivotal Clinical Trial for Alzheimer’s Disease Based on Transcranial Photobiomodulation

Vielight Commences Pivotal Clinical Trial for Alzheimer’s Disease Based on Transcranial Photobiomodulation

Toronto, Canada, Jun. 4 (Korea Bizwire) – Vielight Inc. of Toronto, a leader in brain photobiomodulation (PBM) technology, announces that the primary site for its pivotal clinical trial, St. Michael’s Hospital, in Toronto, has been activated. The trial will be a randomized, placebo-controlled study involving 228 subjects with moderate to severe cognitive impairment due to Alzheimer’s Disease. [...]

Neuralstem Announces Publication of a Study Showing Benefits of Neural Stem Cell (NSC) Transplantation in a Mouse Model of Alzheimer’s Disease

Neuralstem Announces Publication of a Study Showing Benefits of Neural Stem Cell (NSC) Transplantation in a Mouse Model of Alzheimer’s Disease

GERMANTOWN, Md., Oct. 25 (Korea Bizwire) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on developing novel treatments for nervous system diseases, announced the publication of a manuscript in Scientific Reports showing that transplantation of NSI-532.IGF1, a proprietary human neural stem cell line developed by Neuralstem (US patent no 9,750,769), mitigates disease pathology and improves [...]

Neuralstem Announces Presentation of Preclinical Data Demonstrating Neurogenic Compound NSI-189 Improves Cognition and Anxiety in a Mouse Model of Alzheimer’s Disease

Neuralstem Announces Presentation of Preclinical Data Demonstrating Neurogenic Compound NSI-189 Improves Cognition and Anxiety in a Mouse Model of Alzheimer’s Disease

GERMANTOWN, Md., Jul. 23 (Korea Bizwire) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced the presentation of data at the Alzheimer’s Association International Conference in Chicago, Illinois, demonstrating that oral administration of NSI-189 in a mouse model of Alzheimer’s Disease leads to a significant amelioration and/or improvement [...]

Ginseng Consumption Fosters Cognitive Abilities in Senior Citizens: Study

Ginseng Consumption Fosters Cognitive Abilities in Senior Citizens: Study

SEOUL, Jul. 11 (Korea Bizwire) — A new study has found that people who consume ginseng on a regular basis have better cognitive abilities than those who do not. A medical research team at the Seoul National Unversity Bundang Hospital led by Prof. Kim Gi-ung revealed yesterday that the team had observed 6,422 senior citizens [...]

Novel Alzheimer’s Disease Candidate Developed by Megabiowood Pending for Clinical Trials at Post Year

Novel Alzheimer’s Disease Candidate Developed by Megabiowood Pending for Clinical Trials at Post Year

SEOUL, Jun. 23 (Korea Bizwire) — Novel Alzheimer’s disease (AD) medication developed by Megabiowood research team is planning for phase I clinical trial in next year. The novel medication is appraised to have high commercial possibilities as its aspects which shows non-cytotoxicity and superior absorbency that solves not only the symptoms but also the cause [...]

General Anesthesia Could Contribute to Dementia

General Anesthesia Could Contribute to Dementia

SEOUL, Jun. 12 (Korea Bizwire) — A new study has revealed that middle-aged adults who go under general anesthesia are 29 percent more likely to suffer from Alzheimer’s disease than those who don’t. Although patients should not be afraid of going under general anesthesia, the study suggests that a patient’s cognitive performance should be checked [...]

Taconic Biosciences Announces Expansion of Key Alzheimer Animal Model

Taconic Biosciences Announces Expansion of Key Alzheimer Animal Model

HUDSON, N.Y., May 3 (Korea Bizwire) — Taconic Biosciences, a global leader in genetically engineered mouse models and associated services, announced it will expand the offering of a key Alzheimer’s Disease (AD) mouse model, APPSWE – Model 1349, to include aged animals. Taconic will now offer off-the-shelf Model 1349 animals aged up to 42 weeks, [...]